A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung Cancer
Clinical trial NCT07418931 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07418931
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-05-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.